January 11, 2024
According to credible sources, the much-anticipated film ‘Saindhav,’ featuring Venkatesh is rumored to revolve around Zolgensma, recognized as the most expensive drug. This injectable therapy is a form of One-Time Gene Therapy for Spinal Muscular Atrophy that is valued at over Rs. 17 crores which is originated from the United States, as disclosed by an insider. The film not only aims to highlight the extravagant costs of such medications but also aims to expose illegal practices within the pharmaceutical industry and its unethical connections with corporate hospitals.
In a departure from his usual fun-centric roles, Venkatesh is expected to champion a social cause in ‘Saindhav,’ presenting the audience with a new dimension to his on-screen persona. By confronting the influential figures of corporate wrongdoing and their partners, the character portrayed by the actor strives to instigate change and enhance the accessibility of medical care for the common man.
The film is anticipated to navigate through the intricacies of family dynamics, emphasizing the relationships among the father, wife, and daughter before delving into the medical mafia. This distinctive plot choice distinguishes ‘Saindhav’ as a pioneer in Telugu cinema, promising an engaging experience for Venkatesh’s fans and a broader audience.
Directed by promising Sailesh, Known for his precious investigative cop dramas like ‘Hit 1’ and ‘Hit 2’ the film reportedly surpassed its budget, marking it as the directors most expensive project in his the film reportedly surpassed its budget, marking it as the director’s most expensive project in his rising career. Despite the substantial financial investment, ‘Saindhav’ is poised to deliver a compelling narrative that addresses significant societal issues, reaffirming Venkatesh’s dedication to diverse and socially relevant storytelling.
Read More: Guntur Kaaram Massive Pre-Release Sales
